Veeva Systems (VEEV)

NYSE Market Closed

Veeva Systems Inc. provides cloud software built specifically for the life sciences industry. Its customers include pharmaceutical companies, biotechnology developers, contract research organizations, and medical technology businesses that need systems designed around regulated sales, clinical, quality, regulatory, and content workflows.

The company’s commercial software roots are in Veeva CRM, a customer relationship management platform used by life sciences sales and medical teams to manage interactions with healthcare professionals and other stakeholders. Veeva is also expanding around Vault CRM, which brings commercial customer engagement into its broader Vault platform. Veeva Vault is a suite of cloud applications and content management tools that supports functions such as clinical operations, regulatory submissions, quality management, safety, medical affairs, and promotional materials.

Veeva’s distinction is its industry-specific focus. Rather than selling generic enterprise software that life sciences companies must heavily customize, Veeva designs applications around the compliance, documentation, and process requirements of drug and device development and commercialization. This helps customers replace older legacy systems, improve auditability, and standardize workflows across global teams.

The business is primarily subscription-based, with additional revenue from professional services that support implementation and customer adoption. Veeva operates as a vertical cloud software provider, meaning its growth depends on continued digital transformation in life sciences, expansion of its product suite, and the ability to deepen relationships with large global customers while remaining useful to smaller emerging biotech companies.

178.72 USD
168.25 USD
−4.22 (-2.31%)
After-hours

Last updated

Market Cap
29.86B
P/E
32.85
P/FCF
21.54
P/S
9.34
Enterprise Value
28.43B
Sector
Industrials
Industry
Prepackaged Software
Address
4280 HACIENDA DRIVE, PLEASANTON, CA, 94588
GlobeNewswire Inc.

Accumulus Technologies gibt die Live-Integration mit Veeva RIM bekannt und ermöglicht damit eine nahtlose Verbindung zwischen RIM und den Aufsichtsbehörden

07 May 2026, 19:48 PM
GlobeNewswire Inc.

Accumulus Technologies annonce la mise en service de son intégration avec Veeva RIM, permettant une connexion fluide entre les systèmes RIM et les autorités réglementaires

07 May 2026, 19:48 PM
GlobeNewswire Inc.

Clinical Trial Management System Research Report 2026: $4.2 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

24 Apr 2026, 11:56 AM
GlobeNewswire Inc.

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F

24 Apr 2026, 11:54 AM
GlobeNewswire Inc.

Clinical Trial Software Research Report 2026: $2.5+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

24 Apr 2026, 10:55 AM
GlobeNewswire Inc.

Pharmacovigilance Market Size to Reach USD 24.69 Billion by 2035 Owing to the Surging Demand for Drug Safety Monitoring Solutions Globally

25 Feb 2026, 11:00 AM
GlobeNewswire Inc.

Clinical Trials Support Software Solutions in a $34.15B Trial Economy by 2035

18 Feb 2026, 17:00 PM
Investing.com

Down 20%: These 3 Software Stocks Are Boosting Buybacks

13 Jan 2026, 18:13 PM
GlobeNewswire Inc.

Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - SNS Insider

14 Dec 2025, 15:10 PM
GlobeNewswire Inc.

HealthEx appoints Jeremy Schwarz as Chief Commercial Officer

19 Nov 2025, 17:00 PM
Investing.com

BlackRock Fund Dividend Reset Offers 9.2% Yield at a Discount

17 Sept 2025, 11:13 AM
GlobeNewswire Inc.

Close-Up International Appoints Jim Barone as Executive Vice President of Business Solutions to Continue Launch into US Pharma CRM Market

01 Jul 2025, 13:00 PM
GlobeNewswire Inc.

Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity

04 Jun 2025, 12:00 PM
GlobeNewswire Inc.

Accumulus Synergy et Veeva Systems s’associent afin d’accélérer la transformation réglementaire et la connectivité

04 Jun 2025, 12:00 PM
GlobeNewswire Inc.

eClinical Solutions Market Size to Lead USD 40,500 Million by 2034, Growth in the Biopharmaceutical and Pharmaceutical Industry

06 May 2025, 17:00 PM
GlobeNewswire Inc.

Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031

27 Jan 2025, 11:48 AM
Investing.com

Veeva Systems names new CFO in leadership shakeup By Investing.com - Investing.com Canada

16 Jul 2024, 02:59 AM
Zacks Investment Research

Reasons to Retain Veeva Systems (VEEV) in Your Portfolio Now - Zacks Investment Research

15 Jul 2024, 15:30 PM
Investing.com

Veeva Systems CMO resigns, interim leader planned - Investing.com

13 Jul 2024, 03:35 AM
Zacks Investment Research

Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term

26 Jun 2024, 15:45 PM
Market Cap
29.86B
Enterprise Value
28.43B
P/E
32.85
P/B
4.14
P/S
9.34
EV / EBITDA
29.79
EV / Sales
8.9
EPS
5.57
Dividend Yield
0%
P/FCF
21.54
P/CF
21.1
Free Cash Flow
1.39B
ROE
12.6%
ROA
10.12%
Debt / Equity
0
Current Ratio
4.89
Quick Ratio
4.89
Cash
0.87
Avg Volume
3.87M
Fundamentals Snapshot Price
182.94

Income Statement

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Revenue 835.95M 811.24M 789.08M 759.04M 720.89M
Gross profit 622.47M 611.77M 593.83M 585.22M 539.9M
Operating income 245.88M 240.85M 195.91M 233.73M 188.42M
EBITDA 254.19M 250.56M 206.03M 243.55M 198.36M
Net income 244.2M 236.2M 200.31M 228.19M 195.63M
Basic EPS 1.49 1.44 1.23 1.4 1.2
Diluted EPS 1.48 1.4 1.19 1.37 1.17

Balance Sheet

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Total assets 8.98B 8.1B 8B 7.77B 7.34B
Total liabilities 1.76B 1.06B 1.36B 1.55B 1.51B
Total equity 7.21B 7.04B 6.64B 6.21B 5.83B
Cash & equivalents 1.42B 1.66B 1.93B 1.96B 1.12B
Current assets 8B 7.11B 6.99B 6.71B 6.31B
Current liabilities 1.64B 944.88M 1.26B 1.46B 1.4B

Cash Flow

Line Item 2026 Q4 2026 Q3 2026 Q2 2026 Q1 2025 Q4
Operating cash flow 106.85M 192.79M 238.43M 877.16M 69.54M
Investing cash flow -167.75M -495.23M -389.27M -52.11M -15.69M
Financing cash flow -178.05M 32.65M 115.69M 20.38M 20.81M
Change in cash -238.9M -270.29M -34.55M 846.2M 74.27M
Kind Filing Date Link
edgar index DEF 14A — VEEVA SYSTEMS INC View Filing
edgar index DEFA14A — VEEVA SYSTEMS INC View Filing
edgar index ARS — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Hung Priscilla View Filing
edgar index 8-K — VEEVA SYSTEMS INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 144 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Hung Priscilla View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
form 4 Form 4 — Van Wagener Brian View Filing
form 4 Form 4 — Van Wagener Brian View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Faddis Jonathan View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Zuppas Eleni Nitsa View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Kondath Vipin View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
form 4 Form 4 — Van Wagener Brian View Filing
form 4 Form 4 — Van Wagener Brian View Filing
form 4 Form 4 — Van Wagener Brian View Filing
edgar index SCHEDULE 13G/A — VEEVA SYSTEMS INC View Filing
edgar index 10-K — VEEVA SYSTEMS INC View Filing
edgar index S-8 — VEEVA SYSTEMS INC View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Schwenger Thomas D. View Filing
edgar index 8-K — VEEVA SYSTEMS INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
edgar index 4 — VEEVA SYSTEMS INC View Filing
form 4 Form 4 — Ritter Gordon View Filing
form 4 Form 4 — Ritter Gordon View Filing
form 4 Form 4 — Ritter Gordon View Filing
form 4 Form 4 — Ritter Gordon View Filing